Breast tomosynthesis. 3-D mammography reaches the U.S. market.
After many years of anticipation, FDA has approved a device for breast tomosynthesis applications: The Hologic Selenia Dimensions 3-D. But despite the advantages of the technology, certain issues--such as increased radiation dose, higher costs, and lack of insurance reimbursement--may impede widespread clinical adoption. We take a look at breast tomosynthesis and give our view on its clinical outlook.